Intersect ENT Competitors and Similar CompaniesClear all
Intersect ENT's competitors and similar companies include Stryker, Lyra Therapeutics, Regeneron Pharmaceuticals and OptiNose.
 Intersect ENT Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company. |  Stryker Stryker is a company that develops medical, surgical, neurotechnology, orthopedics, and spine products. |  Lyra Therapeutics Lyra Therapeutics is a therapeutics company focused on the development of integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. |  Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines. | ||
Founding Date | Founding Date 2003 | Founding Date 1941 | Founding Date 2005 | Founding Date 1988 | Founding Date 2000 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Menlo Park, US HQ | Locations Watertown, US HQ | Locations Tarrytown, US HQ Mississauga, CA Courbevoie, FR München, DE Bengaluru, IN Dublin, IE Limerick, IE see more | Locations Morrisville, US HQ Oslo, NO Swindon, GB | |
Employees | Employees 4337% increase | Employees 53,0002% increase | Employees 34 | Employees 15,1068% increase | Employees 2048% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 135 b | Valuation ($) 17.4 m | Valuation ($) 102.2 b | Valuation ($) 118.1 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $106.7m (FY, 2021) | Revenue (est.) $25.1b (FY, 2025) | Revenue (est.) $398k (FY, 2025) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) $78.2m (FY, 2024) |
Cost of goods | Cost of goods $30m (FY, 2021) | Cost of goods $9.1b (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods $7.2m (FY, 2024) |
Gross profit | Gross profit $76.7m (FY, 2021) | Gross profit $16.1b (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit $71m (FY, 2024) |
Net income | Net income ($159.6m) (FY, 2021) | Net income $3.2b (FY, 2025) | Net income ($28.9m) (FY, 2025) | Net income $4.5b (FY, 2025) | Net income ($21.5m) (FY, 2024) |
Operating ⚠ | |||||
Patents (US) | Patents (US) 30 (FY, 2016) | Patents (US) N/A | Patents (US) N/A | Patents (US) 31 (FY, 2020) | Patents (US) 43 (Jun, 2017) |
Products | Products 2 (FY, 2016) | Products N/A | Products N/A | Products 11 (FY, 2022) | Products N/A |
Trademarks | Trademarks 29 (FY, 2016) | Trademarks N/A | Trademarks N/A | Trademarks 20 (FY, 2022) | Trademarks N/A |
Trademarks (US) | Trademarks (US) 4 (FY, 2016) | Trademarks (US) N/A | Trademarks (US) N/A | Trademarks (US) N/A | Trademarks (US) 3 (Jun, 2017) |
Funding | |||||
Total funding raised | Total funding raised $ 102.9m | Total funding raised N/A | Total funding raised $ 59.5m | Total funding raised $ 53.9m | Total funding raised $ 120.5m |
For sources of this data, please see the company profile
View Company Profiles
Stryker
HQ
Portage, US
Employees
53,000↑ 2% increase
Stryker is a company that develops medical, surgical, neurotechnology, orthopedics, and spine products.
View companyLyra Therapeutics
HQ
Watertown, US
Employees
34
Lyra Therapeutics is a therapeutics company focused on the development of integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases.
View companyRegeneron Pharmaceuticals
HQ
Tarrytown, US
Employees
15,106↑ 8% increase
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
View company
OptiNose
HQ
Morrisville, US
Employees
204↓ 8% decrease
OptiNose develops nasal drug delivery technologies and combination drug-device therapies.
View company